213
Views
6
CrossRef citations to date
0
Altmetric
Original Research

CTX-M-15 Positive Escherichia coli and Klebsiella pneumoniae Outbreak in the Neonatal Intensive Care Unit of a Maternity Hospital in Ha’il, Saudi Arabia

, , , , , , , ORCID Icon & ORCID Icon show all
Pages 2843-2849 | Published online: 23 Jul 2021

Figures & data

Table 1 Specific PCR Primer Pairs Used in This Study.

Figure 1 PFGE patterns from 19 ESBL-positive E. coli isolates obtained from an NICU outbreak of infection from Ha’il, Saudi Arabia in 2014. Cluster analysis was performed using the method of DICE with UPGMA with band tolerances set to 1.0%. MIC values (µg/mL): amikacin (AK) S = ≤16; gentamicin (GM) S = ≤4; tobramycin (TOB) S ≤4, I = 8; ampicillin (AMP) S ≤8, R ≥32; cefoxitin (CFT) R ≥32; ceftazidime (CAZ) S ≤4, R ≥16; ciprofloxacin (CIP) S ≤0.25; levofloxacin (LEVO) S ≤0.5, imipenem (IMI) S ≤1. Abbreviations: MLST, 131 - Multilocus sequence type 131. TEM, N - no TEM gene detected; 1 - TEM 1 detected. SHV, N - no SHV gene detected; 2 - SHV 2 detected; 12 - SHV 12 detected. CTX-M, 15 - CTX-M-15 detected.

Figure 1 PFGE patterns from 19 ESBL-positive E. coli isolates obtained from an NICU outbreak of infection from Ha’il, Saudi Arabia in 2014. Cluster analysis was performed using the method of DICE with UPGMA with band tolerances set to 1.0%. MIC values (µg/mL): amikacin (AK) S = ≤16; gentamicin (GM) S = ≤4; tobramycin (TOB) S ≤4, I = 8; ampicillin (AMP) S ≤8, R ≥32; cefoxitin (CFT) R ≥32; ceftazidime (CAZ) S ≤4, R ≥16; ciprofloxacin (CIP) S ≤0.25; levofloxacin (LEVO) S ≤0.5, imipenem (IMI) S ≤1. Abbreviations: MLST, 131 - Multilocus sequence type 131. TEM, N - no TEM gene detected; 1 - TEM 1 detected. SHV, N - no SHV gene detected; 2 - SHV 2 detected; 12 - SHV 12 detected. CTX-M, 15 - CTX-M-15 detected.

Figure 2 PFGE patterns from 42 ESBL-positive K. pneumoniae isolates obtained from an NICU outbreak of infection from Ha’il, Saudi Arabia in 2014. Cluster analysis was performed using the method of DICE with UPGMA with band tolerances set to 1.0%. MIC values (µg/mL): amikacin (AK) S ≤16, I = 32; gentamicin (GM) S ≤4, R ≥16; tobramycin (TOB) S ≤4, I = 8, R ≥16; ampicillin (AMP) R ≥32; cefoxitin (CFT) R ≥32; ceftazidime (CAZ) S ≤4, R ≥16; ciprofloxacin (CIP) S ≤0.25, R ≥1; levofloxacin (LEVO) S ≤0.5, R ≥2; imipenem (IMI) S ≤1. Abbreviations: MLST, 14 - Multilocus sequence type 14. TEM, N - no TEM gene detected; 1 - TEM 1 detected. SHV, N - no SHV gene detected; 12 - SHV 12 detected. CTX-M, N - no CTX-M gene detected; 15 - CTX-M-15 detected.

Figure 2 PFGE patterns from 42 ESBL-positive K. pneumoniae isolates obtained from an NICU outbreak of infection from Ha’il, Saudi Arabia in 2014. Cluster analysis was performed using the method of DICE with UPGMA with band tolerances set to 1.0%. MIC values (µg/mL): amikacin (AK) S ≤16, I = 32; gentamicin (GM) S ≤4, R ≥16; tobramycin (TOB) S ≤4, I = 8, R ≥16; ampicillin (AMP) R ≥32; cefoxitin (CFT) R ≥32; ceftazidime (CAZ) S ≤4, R ≥16; ciprofloxacin (CIP) S ≤0.25, R ≥1; levofloxacin (LEVO) S ≤0.5, R ≥2; imipenem (IMI) S ≤1. Abbreviations: MLST, 14 - Multilocus sequence type 14. TEM, N - no TEM gene detected; 1 - TEM 1 detected. SHV, N - no SHV gene detected; 12 - SHV 12 detected. CTX-M, N - no CTX-M gene detected; 15 - CTX-M-15 detected.